Elkem (OB:ELK) has caught some attention recently, with its shares moving over 8% in the past month. Investors have been watching the company's solid revenue and net income growth, looking for clues about what might come next.

See our latest analysis for Elkem.

Elkem's share price has notched a 1-month return of over 8% and is now up around 55% on a total shareholder basis over the past five years. This indicates that momentum is picking up as investors respond to strong business results and improving sentiment.

If Elkem’s recent moves have you curious, it might be the perfect time to broaden your horizons and discover fast growing stocks with high insider ownership

With Elkem’s strong fundamentals and a total shareholder return near 55% over five years, the question remains: is the current price still leaving room for upside, or is the market fully reflecting Elkem’s growth potential?

With Elkem's fair value pegged at NOK27.92 according to the most widely followed narrative, shares now trade just below this price at NOK27.10. This suggests expectations remain constructive but not euphoric as momentum builds.

The diverse geographical presence helps offset negative impacts from global trade tensions. This suggests that Elkem could maintain or increase revenue by leveraging its regional business model. Initiatives to supply the green transition, such as R&D in carbon capture, storage, and using biogenic materials, could enhance long-term revenue and net margins by meeting rising demand for sustainable products.

Read the complete narrative.

Curious what high-stakes assumptions back this precise valuation? There is one bold growth number and a future profit forecast that may surprise even industry insiders. Dig in to see what earnings leap and margin improvements analysts are betting on to justify this fair value.

Result: Fair Value of $27.92 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, global trade tensions and softening demand in critical markets like China and Europe could challenge Elkem’s trajectory in the coming years.

Find out about the key risks to this Elkem narrative.

Looking at Elkem through the lens of our SWS DCF model, the story shifts. The DCF approach suggests the current price of NOK27.10 is well above its estimated fair value of NOK8.55, which raises concerns that shares may be significantly overvalued. Does this method signal a warning others are missing?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Elkem for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

If you see the data differently or want to challenge these assumptions, you can quickly build your own narrative for Elkem in just a few minutes, your own way with Do it your way.

A great starting point for your Elkem research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Don’t let great opportunities slip by. Broaden your scope with these handpicked stock lists that could spark your next big win.

Boost your passive income strategy with attractive yields by checking out 3%;elm:context_link;itc:0;sec:content-canvas\\" class=\\"link \\">these 19 dividend stocks with yields > 3% that consistently outpace the market’s average payouts.

Tap into the potential of technology-driven healthcare progress by reviewing these 32 healthcare AI stocks transforming diagnostics, patient care, and the future of medicine.

Step ahead of the curve by researching these 887 undervalued stocks based on cash flows where market mispricings could offer strong upside for early movers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ELK.ob.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com